EpiPen maker Mylan has been under fire for increasing the price of its life-saving allergy treatment by about 500% since 2009. In response to public outrage, Mylan CEO Heather Bresch told CNBC that the mass price hike is due to our “broken” health system. During “The Quickie,” Ilyssa Fuchs, Esq. explained how and why the price of the EpiPen has risen to over $600 and what this says about our health care system.